# Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

> **NCT00006234** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Metastatic Cancer
- Sarcoma

## Interventions

- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** holmium Ho 166 DOTMP

## Key facts

- **NCT ID:** NCT00006234
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** — (—)
- **Last updated:** 2011-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006234, "Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00006234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*